Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Pfizer Commits 10M Courses Of COVID-19 Oral Antiviral To Developing Countries: Reuters

Pfizer Inc (NYSE:PFE) is expected to provide around 10 million courses of its highly effective COVID-19 antiviral treatment Paxlovid to low- and middle-income countries in 2022, reports Reuters citing an official with the Global Fund. The Fund's head of strategy for policy, Harley Feldbaum, said Pfizer had committed at least that many…

Benzinga

EU clears Moderna shot for young kids, Pfizer boosters

The European Medicines Agency said it has authorized Moderna’s coronavirus vaccine for children aged six to 11, in addition to recommending booster shots of Pfizer’s vaccine for those aged 12 and over

The Independent UK

Why Pfizer Shares Are Trading Higher Today

Pfizer Inc (NYSE: PFE) is trading higher Wednesday after the company received Breakthrough Therapy Designation from the U.S. Food and Drug Administration for PF-06482077, or RSVpreF, the company's respiratory syncytial virus vaccine candidate.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Vaccine mandates: Government to fight fire with science in High Court

Leaders of a group challenging their vaccine mandates this week include a GP suspended for distributing misinformation, and a Northland anti-abortion activist

Newsroom.co.nz

Pfizer to provide 10 million courses of COVID pill to developing countries -the Global Fund

Pfizer Inc is expected to provide around 10 million courses of its highly effective COVID-19 antiviral treatment Paxlovid to low- and middle-income countries this year, according to an official with the Global Fund, a healthcare NGO working to buy the pills from the drugmaker.

Reuters

EXPLAINER: Why Pfizer needs time to make COVID-19 treatment

Pfizer’s new COVID-19 treatment came with a catch when it debuted late last year: It can take months to make the tablets

The Independent UK

Pfizer Covid vaccine less effective in kids aged between five and 11, study finds

Children in this age group are set to receive the Covid jab from later this month.

Daily Record

Read news from The Economist, FT, and more,
with one subscription

Pfizer shots protect kids from severe COVID even in omicron

A new government report shows Pfizer’s COVID-19 vaccine gave children 5 and older strong protection against hospitalization and death even during the omicron surge

The Independent UK

Pfizer/BioNTech's COVID-19 Vaccine Mere 12% Effective In Kids 5-11 Years, New York Study Shows

According to a published study, Pfizer Inc (NYSE: PFE) and BioNTech SE's (NASDAQ: BNTX) two-dose COVID-19 vaccine provided very little protection for children aged 5 to 11 years during the wave of o

Benzinga

Pfizer's Clostridioides Difficile Vaccine Fails To Prevent C. Difficile Infection

Pfizer Inc (NYSE: PFE) announced data from the CLOVER Phase 3 trial evaluating Clostridioides difficile vaccine candidate to prevent C. difficile infection (CDI).

Benzinga

COVID vax: Pregnant women left behind

Clinical trials of COVID vaccines excluded pregnant people, which left many wondering whether to get vaccinated

Salon

A South African company addresses vaccine supply inequity, despite Canada's lack of support

Since late 2020, the inequitable access across the globe to COVID-19 vaccines has been a glaring problem. But a remarkable achievement earlier this month offers hope that the supply of vaccines to developing countries will improve: Afrigen Biologics, a South African based company, produced its own version of Moderna’s mRNA…

The Conversation

Pfizer vaccine significantly less effective in children ages five to 11, study shows

Strikingly higher rates of decline in effectiveness for younger children suggest the lower dose they receive may be the reason

The Guardian - US

Pfizer vaccine much less successful at preventing Covid infections in young children, data shows

‘In the Omicron era, the effectiveness against cases of BNT162b2 declined rapidly for children, particularly those 5-11 years,’ a new study says

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What Are Whales Doing With Pfizer

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 29 strange trades.

Bangkok Post

Drugmakers Reap Billions Meeting Covid-19 Needs

Healthcare companies that came up with effective Covid-19 vaccines, treatments and tests are seeing a huge financial payoff and are starting to spend their cash, while grappling with questions about whether the growth is sustainable.

The Guardian - AU

Covid vaccines for children: how many doses are needed and what happens if they’ve been infected or are under five?

Making sure adults and older children are vaccinated, as well as mask wearing and social distancing, is the best thing to do if worried about under-fives not being eligible, expert says

Los Angeles Times

Q&A: Why the CDC suggests more time between 1st and 2nd COVID vaccine doses for some people

LOS ANGELES — After recommending for more than a year that people wait only a few weeks between their first and second doses of COVID-19 vaccines, the U.S. Centers for Disease Control and Prevention has adjusted its suggested timeline for some people by another month or so.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Longer Waiting Period Between mRNA COVID-19 Doses May Cut Heart Inflammation Risk, CDC Suggests

The Centers for Disease Control and Prevention said that younger males should consider waiting longer between doses of Pfizer Inc's (NYSE: PFE) / BioNTech SE (NASDAQ: BNTX) and Moderna

The Times of India

Pan corona vax in the works: mRNA scientist Drew Weissman

HYDERABAD: At a time when there are fears of the emergence of new Covid-19 variants, American physician-scientist Dr Drew Weissman, who along with Dr Katalin Kariko worked on the mRNA vaccine platform that enabled Pfizer and Moderna to develop Covid-19 vaccines, said his lab was now working on a pan…

Benzinga

Pfizer Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 45 strange trades.

Benzinga

Pfizer's Cannabinoid-Related Biotech Company Arena's Q4 Net Loss Grows 27% YoY

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) revealed Wednesday financial results for the fourth quarter and full year ended Dec. 31, 2021. Q4 Finanical HIghlights

Los Angeles Times

Will you need a 2nd booster shot to keep coronavirus at bay?

With omicron fading and pressure growing to ease mask rules and other pandemic restrictions, there is growing debate among health officials and experts about if or when a second booster shot will be part of this path toward recovery.

The Independent UK

CDC: Some people should wait longer for 2nd COVID shot

U.S. health officials say some people getting Pfizer or Moderna COVID-19 vaccines should consider waiting up to eight weeks between the first and second doses

The Guardian - UK

Covid live: Poland, Slovakia and Iceland latest countries set to end most coronavirus restrictions — as it happened

Move comes as case numbers and deaths continue to fall in many nations

1 … 63 64 65 66

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.